Glen Gejerman, M.D
Glen Gejerman, M.D., Co-Chief Division of Urologic Oncology and Medical Director of TomoTherapy has spearheaded the development of John Theurer Cancer Center's Radiation Oncology Department, one of the largest programs of its kind in New Jersey. Dr. Gejerman is also a member of Regional Cancer Center Associates, New Jersey’s largest oncology physician network.
Dr. Gejerman brings novel techniques and technologies to patients as they emerge. His department offers patients access to every treatment option available, including brachytherapy, TrueBeam, and the TomoTherapy system. TomoTherapy delivers a very sophisticated form of intensity modulated radiation therapy (IMRT) using an integrated treatment system that is unlike any other -- giving patients unparalleled accuracy, precision, and safety.
Dr. Gejerman is dedicated to making radiation therapy safer for patients. He is one the first radiation oncologists in the tri-state area to begin implanting a wireless radiation sensor, which allows oncologists to receive data on the precise amount of radiation being delivered to tumors and surrounding tissue.
- Attending Physician: Assistant Professor of Radiation Oncology, Albert Einstein College of Medicine, Bronx, New York
- Medical Education: UMDNJ-New Jersey Medical School, Newark, New Jersey
- Internships: Long Island Jewish Medical Center, New Hyde Park, New York; Albert Einstein College of Medicine, Bronx, New York
- Radiation Oncology Residency: Montefiore Medical Center and Weiler Hospital, Bronx, New York; Albert Einstein College of Medicine. Bronx, New York
- Specializations: Intensity modulated radiation therapy (IMRT), high-dose rate brachytherapy (HDR) for prostate cancer patients, Tomotherapy and Radioactive Seed Implant
- Research Interests: Investigating all types of radiation therapy for prostate cancer, including intensity modulated radiation therapy, TomoTherapyTM; brachytherapy (radioactive seed implantation) and high-dose-rate brachytherapy (using catheters to deliver the radiation) the use of IMRT and tradiational externla beam radiation therapy to treat other cancers